retatrutide eli lilly Lilly's cuts weight by 17% in diabetes trial Retatrutide, the next generation of

PMID: 20524875 [LoE A] [2] Weschawalit, S., Thongthip, S., Phutrakool, P., & Asawanonda, P

It began with GLP-1s, the weight loss and diabetes drugs that, almost overnight, became the center of every strategy conversation

The TB-500 fragment retains the critical actin-binding and cell-migration-promoting activities of the full-length TB4 molecule, making it the predominant research form used in pre-clinical peptide studies

But the explosive impact of metabolism-correcting, weight-moderating drugs like Ozempic, Wegovy, and Mounjaro also has some prize forecasters wondering if perhaps the discoveries that have led up to these treatments might find their way to the Nobel spotlight